Neoantigen vaccine therapy targeting H3.3-K27M DIPG
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Neoantigen vaccine therapy targeting H3.3-K27M DIPG, covering 2025-06-06 to 2025-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma [Phase 1]